ARCHIVES

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

In Brief: La Jolla Foundation Receives Donated Buildings; Sinks Named Medical Director, Middlesex Hospital

April 27, 1990

Aging Institute Encourages Cancer Investigators To Include Elderly

January 8, 1982

NCI Advisory Group Meetings for July

June 27, 1975